Web Exclusives

January is a time of new beginnings and building resilience by reframing negative habits into more optimistic opportunities. The symbols that represent the month of January are reflective of navigation positive characteristics.

Welcome back to Navigation Refresh, a recurring, informative feature for novice and seasoned patient navigators alike. In this issue, we cover the role of patient navigators in advocacy.

A peer navigation model that addresses barriers to diverse participation and aims to boost enrollment in childhood cancer therapeutic clinical trials is underway and was presented by one of the study researchers at the 66th Annual Meeting of the American Society of Hematology, held in San Diego, CA.

With former President Joe Biden’s prostate cancer diagnosis being thrust onto the world’s stage, it is imperative that we use this as a teachable opportunity to educate people about the disease—and to highlight how oncology navigators make a difference in prostate cancer care.

This groundbreaking study reveals how AI-enabled interventions have the potential to revolutionize patient navigation by reducing burnout, increasing capacity, and creating sustainable healthcare solutions tailored to individual patient needs.

Based on positive results of the KRYSTAL-1 clinical trial, adagrasib was granted accelerated FDA approval for patients with non–small-cell lung cancer harboring the KRAS G12C mutation.

This infographic illustrates key findings from the first-of-its-kind study to examine outcomes, evaluate analytics, identify barriers/challenges, analyze performance improvement processes, and identify opportunities for future research.

These results make quizartinib the first FLT3 inhibitor to demonstrate such improvement over chemotherapy in this patient population.